Cargando…

Vemurafenib and Dabrafenib Downregulates RIPK4 Level

SIMPLE SUMMARY: RIPK4 kinase has oncogenic functions in melanoma and shows high similarity to BRAF protein, making this kinase sensitive to the BRAF inhibitors vemurafenib and dabrafenib. BRAFi downregulates RIPK4 in both BRAF-mutated and wild-type cells. Although downregulation and upregulation of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Madej, Ewelina, Brożyna, Anna A., Adamczyk, Agnieszka, Wronski, Norbert, Harazin-Lechowska, Agnieszka, Muzyk, Anna, Makuch, Krzysztof, Markiewicz, Michal, Rys, Janusz, Wolnicka-Glubisz, Agnieszka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913565/ https://www.ncbi.nlm.nih.gov/pubmed/36765875 http://dx.doi.org/10.3390/cancers15030918

Ejemplares similares

Deciphering the Functional Role of RIPK4 in Melanoma
por: Madej, Ewelina, et al.
Publicado: (2021)

Dual Action of Curcumin as an Anti- and Pro-Oxidant from a Biophysical Perspective
por: Wolnicka-Glubisz, Agnieszka, et al.
Publicado: (2023)

Proteins Involved in HER2 Signalling Pathway, Their Relations and Influence on Metastasis-Free Survival in HER2-Positive Breast Cancer Patients Treated with Trastuzumab in Adjuvant Setting
por: Adamczyk, Agnieszka, et al.
Publicado: (2017)

Relationship between HER2 gene status and selected potential biological features related to trastuzumab resistance and its influence on survival of breast cancer patients undergoing trastuzumab adjuvant treatment
por: Adamczyk, Agnieszka, et al.
Publicado: (2018)

Riboflavin and Its Derivates as Potential Photosensitizers in the Photodynamic Treatment of Skin Cancers
por: Insińska-Rak, Małgorzata, et al.
Publicado: (2023)

Application of high-resolution genomic profiling in the differential diagnosis of liposarcoma
por: Koczkowska, Magdalena, et al.
Publicado: (2017)

HGF/SF Increases Number of Skin Melanocytes but Does Not Alter Quality or Quantity of Follicular Melanogenesis
por: Wolnicka-Glubisz, Agnieszka, et al.
Publicado: (2013)

Reintroduction of dabrafenib after previous vemurafenib-induced DRESS: Not always safe!
por: Luherne, Camille, et al.
Publicado: (2019)

Prolonged Idasanutlin (RG7388) Treatment Leads to the Generation of p53-Mutated Cells
por: Skalniak, Lukasz, et al.
Publicado: (2018)

Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells
por: Möller, Jack K. S., et al.
Publicado: (2023)

Vemurafenib inhibits necroptosis in normal and pathological conditions as a RIPK1 antagonist
por: Sun, Mayu, et al.
Publicado: (2023)

Successful use of dabrafenib after the occurrence of drug rash with eosinophilia and systemic symptoms (DRESS) induced by vemurafenib
por: Pinard, Camille, et al.
Publicado: (2017)

Model based analysis of the heterogeneity in the tumour size dynamics differentiates vemurafenib, dabrafenib and trametinib in metastatic melanoma
por: Mistry, Hitesh B., et al.
Publicado: (2017)

Successful dabrafenib transition after vemurafenib-induced toxic epidermal necrolysis in a patient with metastatic melanoma
por: Tahseen, Ahmed I., et al.
Publicado: (2018)

Low frequency of HPV positivity in breast tumors among patients from south-central Poland
por: Biesaga, Beata, et al.
Publicado: (2021)

Innate immune checkpoint inhibitor resistance is associated with melanoma sub-types exhibiting invasive and de-differentiated gene expression signatures
por: Hossain, Sultana Mehbuba, et al.
Publicado: (2022)

Leukocyte Count Restoration Under Dabrafenib Treatment in a Melanoma Patient With Vemurafenib-Induced Leukopenia: Case Report
por: Orouji, Elias, et al.
Publicado: (2014)

Fertility Outcomes and Sperm-DNA Parameters in Metastatic Melanoma Survivors Receiving Vemurafenib or Dabrafenib Therapy: Case Report
por: Ghezzi, Marco, et al.
Publicado: (2020)

Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients
por: Daud, Adil, et al.
Publicado: (2017)

Quantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC–MS/MS
por: Krens, Stefanie D., et al.
Publicado: (2020)

Ultraviolet Radiation-Induced Mitochondrial Disturbances Are Attenuated by Metabolites of Melatonin in Human Epidermal Keratinocytes
por: Holtkamp, Chantal E., et al.
Publicado: (2023)

Differential Expression of BARD1 Isoforms in Melanoma
por: McDougall, Lorissa I., et al.
Publicado: (2021)

Vemurafenib and Rituximab in Patients with Hairy Cell Leukemia Previously Treated with Moxetumomab Pasudotox
por: Robak, Tadeusz, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of Dabrafenib Plus Trametinib and Vemurafenib as First-Line Treatment in Patients with BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma in China
por: Gao, Tianfu, et al.
Publicado: (2021)

RIPK1 downregulation enhances neutrophil extracellular traps in psoriasis
por: Meng, Xinyu, et al.
Publicado: (2022)

B-RAF(V600E) Inhibitor Dabrafenib Attenuates RIPK3-Mediated Necroptosis and Promotes Functional Recovery after Spinal Cord Injury
por: Sugaya, Takehiro, et al.
Publicado: (2019)

Bio-Herbicidal Potential of Nanoemulsions with Peppermint Oil on Barnyard Grass and Maize
por: Rys, Magdalena, et al.
Publicado: (2022)

Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors
por: Jurga, Agnieszka M., et al.
Publicado: (2018)

Plasma protein changes reflect colorectal cancer development and associated inflammation
por: Urbiola-Salvador, Víctor, et al.
Publicado: (2023)

Melanoma induction by ultraviolet A but not ultraviolet B radiation requires melanin pigment
por: Noonan, Frances P., et al.
Publicado: (2012)

Combined vemurafenib and fotemustine in patients with BRAF V600 melanoma progressing on vemurafenib
por: Queirolo, Paola, et al.
Publicado: (2016)

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model
por: Jurga, Agnieszka M., et al.
Publicado: (2016)

Long-Term Real-World Outcomes and Safety of Vemurafenib and Vemurafenib + Cobimetinib Therapy in Patients with BRAF-Mutated Melanoma
por: Piejko, Karolina, et al.
Publicado: (2023)

MCPIP1 inhibits Wnt/β-catenin signaling pathway activity and modulates epithelial-mesenchymal transition during clear cell renal cell carcinoma progression by targeting miRNAs
por: Gorka, Judyta, et al.
Publicado: (2021)

MUC1 downregulation promotes TNF‐α‐induced necroptosis in human bronchial epithelial cells via regulation of the RIPK1/RIPK3 pathway
por: Zhang, Huojun, et al.
Publicado: (2019)

Dabrafenib Treatment in a Patient with an Epithelioid Glioblastoma and BRAF V600E Mutation
por: Ceccon, Garry, et al.
Publicado: (2018)

Clinical aspects of Emery-Dreifuss muscular dystrophy
por: Madej-Pilarczyk, Agnieszka
Publicado: (2018)

Effect of Chemotherapeutic Drugs on Caspase-3 Activity, as a Key Biomarker for Apoptosis in Ovarian Tumor Cell Cultured as Monolayer. A Pilot Study
por: Gregoraszczuk, Ewa L, et al.
Publicado: (2015)

Iridophoroma associated with the Lemon Frost colour morph of the leopard gecko (Eublepharis macularius)
por: Szydłowski, Paweł, et al.
Publicado: (2020)

Author Correction: Iridophoroma associated with the Lemon Frost colour morph of the leopard gecko (Eublepharis macularius)
por: Szydłowski, Paweł, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sa7t77kct7hpptnp15ilel61kq